UK Supreme Court affirms Warner-Lambert’s pregabalin patent is invalid
Warner-Lambert patent was insufficiently disclosed and would not have been infringed by generics even if the claims were valid, in a ruling that raises the bar for plausibility of Swiss form claims
Warner-Lambert has lost in a highly-anticipated judgment issued by the UK Supreme Court today, in Warner Lambert v Generics.
The case concerns the drug pregabalin, and the question of how the concepts of sufficiency and infringement are to be...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.